ArticleNature medicine2018

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.

Joseph A Fraietta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.